Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Fleshner

Showing results (231-240 of 266) with videos related to

Pageof 27
Sort By:
Oncotarget|May 3, 2017
Metabolic heterogeneity signature of primary treatment-naïve prostate cancerDong Lin, Susan L Ettinger, Sifeng Qu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 1, 2014
Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of CanadaMichael Organ, Michael Jewett, Joan Basiuk, et al.
European Urology Focus|July 5, 2020
The Suggested Unique Association Between the Various Statin Subgroups and Prostate CancerHanan Goldberg, Faizan K Mohsin, Refik Saskin, et al.
The Journal of Urology|May 15, 2018
Evaluation of an Aggressive Prostate Biopsy Strategy in Men Younger than 50 YearsHanan Goldberg, Zachary Klaassen, Thenappan Chandrasekar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2026
131I-LNTH-1095 Radioligand Therapy Plus Enzalutamide vs. Enzalutamide Alone in Men With PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase 2 StudyEvan Y Yu, Vivek Narayan, Giuseppe Esposito, et al.
The Journal of Molecular Diagnostics : JMD|March 6, 2016
Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy SpecimensBeatrice S Knudsen, Hyung L Kim, Nicholas Erho, et al.
Urologic Oncology|April 8, 2020
Psychological distress associated with active surveillance in patients younger than 70 with a small renal massHanan Goldberg, Rami Ajaj, Jaime Omar Herrera Cáceres, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 28, 2020
Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialistsSebastien J Hotte, Antonio Finelli, Kim N Chi, et al.
The Journal of Urology|April 8, 2020
Does Time Spent on Active Surveillance Adversely Affect the Pathological and Oncologic Outcomes in Patients Undergoing Delayed Radical Prostatectomy?Ardalan E Ahmad, Patrick O Richard, Ricardo Leão, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 30, 2014
Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO)Suzanne Richter, J Dean Ruether, Lori Wood, et al.
Pageof 27

Showing results (231-240 of 266) with videos related to

Sort By:
Pageof 27
Oncotarget|May 3, 2017
Metabolic heterogeneity signature of primary treatment-naïve prostate cancerDong Lin, Susan L Ettinger, Sifeng Qu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 1, 2014
Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of CanadaMichael Organ, Michael Jewett, Joan Basiuk, et al.
European Urology Focus|July 5, 2020
The Suggested Unique Association Between the Various Statin Subgroups and Prostate CancerHanan Goldberg, Faizan K Mohsin, Refik Saskin, et al.
The Journal of Urology|May 15, 2018
Evaluation of an Aggressive Prostate Biopsy Strategy in Men Younger than 50 YearsHanan Goldberg, Zachary Klaassen, Thenappan Chandrasekar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2026
131I-LNTH-1095 Radioligand Therapy Plus Enzalutamide vs. Enzalutamide Alone in Men With PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase 2 StudyEvan Y Yu, Vivek Narayan, Giuseppe Esposito, et al.
The Journal of Molecular Diagnostics : JMD|March 6, 2016
Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy SpecimensBeatrice S Knudsen, Hyung L Kim, Nicholas Erho, et al.
Urologic Oncology|April 8, 2020
Psychological distress associated with active surveillance in patients younger than 70 with a small renal massHanan Goldberg, Rami Ajaj, Jaime Omar Herrera Cáceres, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 28, 2020
Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialistsSebastien J Hotte, Antonio Finelli, Kim N Chi, et al.
The Journal of Urology|April 8, 2020
Does Time Spent on Active Surveillance Adversely Affect the Pathological and Oncologic Outcomes in Patients Undergoing Delayed Radical Prostatectomy?Ardalan E Ahmad, Patrick O Richard, Ricardo Leão, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 30, 2014
Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO)Suzanne Richter, J Dean Ruether, Lori Wood, et al.
Pageof 27